Advancements of compounds targeting Wnt and Notch signalling pathways in the treatment of inflammatory bowel disease and colon cancer

References

• Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol. 2014;14:141–153.
   PubMed Web of Science ®Google Scholar
• Allaire JM, Crowley SM, Law HT, et al. The intestinal epithelium: central coordinator of mucosal immunity. Trends Immunol. 2018;39:677–696.
   PubMed Web of Science ®Google Scholar
• Gehart H, Clevers H. Tales from the crypt: new insights into intestinal stem cells. Nat Rev Gastroenterol Hepatol. 2019;16:19–34.
   PubMed Web of Science ®Google Scholar
• Kim YS, Ho SB. Intestinal goblet cells and mucins in health and disease: recent insights and progress. Curr Gastroenterol Rep. 2010;12:319–330.
   PubMedGoogle Scholar
• Massague J. TGFbeta signalling in context. Nat Rev Mol Cell Biol. 2012;13:616–630.
   PubMed Web of Science ®Google Scholar
• Gregorieff A, Wrana JL. Hippo signalling in intestinal regeneration and cancer. Curr Opin Cell Biol. 2017;48:17–25.
   PubMed Web of Science ®Google Scholar
• Cui S, Chang PY. Current understanding concerning intestinal stem cells. World J Gastroenterol. 2016;22:7099–7110.
   PubMed Web of Science ®Google Scholar
• Sancho R, Cremona CA, Behrens A. Stem cell and progenitor fate in the mammalian intestine: Notch and lateral inhibition in homeostasis and disease. EMBO Rep. 2015;16:571–581.
   PubMed Web of Science ®Google Scholar
• Nusse R, Clevers H. Wnt/β-catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169:985–999.
   PubMed Web of Science ®Google Scholar
• Scoville DH, Sato T, He XC, et al. Current view: intestinal stem cells and signaling. Gastroenterology. 2008;134:849–864.
   PubMed Web of Science ®Google Scholar
• Pandurangan AK, Divya T, Kumar K, et al. Colorectal carcinogenesis: insights into the cell death and signal transduction pathways: A review. World J Gastrointest Oncol. 2018;10:244–259.
   PubMed Web of Science ®Google Scholar
• Gersemann M, Stange EF, Wehkamp J. From intestinal stem cells to inflammatory bowel diseases. World J Gastroenterol. 2011;17:3198–3203.
   PubMed Web of Science ®Google Scholar
• VanderVorst K, Dreyer CA, Konopelski SE, et al. Wnt/PCP signaling contribution to carcinoma collective cell migration and metastasis. Cancer Res. 2019;79:1719–1729.
   PubMed Web of Science ®Google Scholar
• Guo J, Li P, Liu X, et al. NOTCH signaling pathway and non-coding RNAs in cancer. Pathol Res Pract. 2019;215:152620.
   PubMed Web of Science ®Google Scholar
• Aithal MG, Rajeswari N. Role of Notch signalling pathway in cancer and its association with DNA methylation. J Genet. 2013;92:667–675.
   PubMed Web of Science ®Google Scholar
• Mazzoni SM, Fearon ER. AXIN1 and AXIN2 variants in gastrointestinal cancers. Cancer Lett. 2014;355:1–8.
   PubMed Web of Science ®Google Scholar
• Buchert M, Rohde F, Eissmann M, et al. A hypermorphic epithelial β-catenin mutation facilitates intestinal tumorigenesis in mice in response to compounding WNT-pathway mutations. Dis Model Mech. 2015;8:1361–1373.
   PubMed Web of Science ®Google Scholar
• Garg P, Sarma D, Jeppsson S, et al. Matrix metalloproteinase-9 functions as a tumor suppressor in colitis-associated cancer. Cancer Res. 2010;70:792–801.
   PubMed Web of Science ®Google Scholar
• Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006;127:469–480.
   PubMed Web of Science ®Google Scholar
• Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004;20:781–810.
   PubMed Web of Science ®Google Scholar
• Niehrs C. The complex world of WNT receptor signalling. Nat Rev Mol Cell Biol. 2012;13:767–779.
   PubMed Web of Science ®Google Scholar
• Simons M, Mlodzik M. Planar cell polarity signaling: from fly development to human disease. Annu Rev Genet. 2008;42:517–540.
   PubMed Web of Science ®Google Scholar
• Luu HH, Zhang R, Haydon RC, et al. Wnt/beta-catenin signaling pathway as a novel cancer drug target. Curr Cancer Drug Targets. 2004;4:653–671.
   PubMed Web of Science ®Google Scholar
• Inestrosa NC, Varela-Nallar L. Wnt signaling in the nervous system and in Alzheimer’s disease. J Mol Cell Biol. 2014;6:64–74.
   PubMed Web of Science ®Google Scholar
• Koval A, Katanaev VL. Dramatic dysbalancing of the Wnt pathway in breast cancers. Sci Rep. 2018;8:7329.
   PubMed Web of Science ®Google Scholar
• Lietman C, Wu B, Lechner S, et al. Inhibition of Wnt/beta-catenin signaling ameliorates osteoarthritis in a murine model of experimental osteoarthritis. JCI Insight. 2018;3:e96308.
   PubMed Web of Science ®Google Scholar
• Pak S, Park S, Kim Y, et al. The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway. J Exp Clin Cancer Res. 2019;38:342.
   PubMed Web of Science ®Google Scholar
• Andreu P, Colnot S, Godard C, et al. Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine. Development. 2005;132:1443–1451.
   PubMed Web of Science ®Google Scholar
• Wehkamp J, Wang G, Kübler I, et al. The Paneth cell alpha-defensin deficiency of ileal Crohn’s disease is linked to Wnt/Tcf-4. J Immunol. 2007;179:3109–3118.
   PubMed Web of Science ®Google Scholar
• Cappell MS. Pathophysiology, clinical presentation, and management of colon cancer. Gastroenterol Clin North Am. 2008;37:1–24, v.
   PubMed Web of Science ®Google Scholar
• Kaemmerer E, Jeon MK, Berndt A, et al. Targeting Wnt signaling via notch in intestinal carcinogenesis. Cancers. 2019;11:555.
   Web of Science ®Google Scholar
• Krausova M, Korinek V. Wnt signaling in adult intestinal stem cells and cancer. Cell Signal. 2014;26:570–579.
   PubMed Web of Science ®Google Scholar
• Moparthi L, Koch S. Wnt signaling in intestinal inflammation. Differentiation. 2019;108:24–32.
   PubMed Web of Science ®Google Scholar
• Chae WJ, Bothwell ALM. Canonical and non-canonical wnt signaling in immune cells. Trends Immunol. 2018;39:830–847.
   PubMed Web of Science ®Google Scholar
• Jiang L, Yin M, Wei X, et al. Bach1 represses Wnt/β-catenin signaling and angiogenesis. Circ Res. 2015;117:364–375.
   PubMed Web of Science ®Google Scholar
• Nuñez F, Bravo S, Cruzat F, et al. Wnt/β-catenin signaling enhances cyclooxygenase-2 (COX2) transcriptional activity in gastric cancer cells. PLoS One. 2011;6:e18562.
   PubMed Web of Science ®Google Scholar
• Nava P, Koch S, Laukoetter MG, et al. Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways. Immunity. 2010;32:392–402.
   PubMed Web of Science ®Google Scholar
• Zhao X, Ma L, Dai L, et al. TNF‐α promotes the malignant transformation of intestinal stem cells through the NF‐κB and Wnt/β‐catenin signaling pathways. Oncol Rep. 2020;44:577–588.
   PubMed Web of Science ®Google Scholar
• Bray SJ. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol. 2006;7:678–689.
   PubMed Web of Science ®Google Scholar
• Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science. 1999;284:770–776.
   PubMed Web of Science ®Google Scholar
• Greenwald I. LIN-12/Notch signaling: lessons from worms and flies. Genes Dev. 1998;12:1751–1762.
   PubMed Web of Science ®Google Scholar
• Fortini ME. Gamma-secretase-mediated proteolysis in cell-surface-receptor signalling. Nat Rev Mol Cell Biol. 2002;3:673–684.
   PubMed Web of Science ®Google Scholar
• Mumm JS, Kopan R. Notch signaling: from the outside in. Dev Biol. 2000;228:151–165.
   PubMed Web of Science ®Google Scholar
• Fre S, Huyghe M, Mourikis P, et al. Notch signals control the fate of immature progenitor cells in the intestine. Nature. 2005;435:964–968.
   PubMed Web of Science ®Google Scholar
• Carulli AJ, Keeley TM, Demitrack ES, et al. Notch receptor regulation of intestinal stem cell homeostasis and crypt regeneration. Dev Biol. 2015;402:98–108.
   PubMed Web of Science ®Google Scholar
• van Es JH, van Gijn ME, Riccio O, et al. Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature. 2005;435:959–963.
   PubMed Web of Science ®Google Scholar
• Ghorbaninejad M, Heydari R, Mohammadi P, et al. Contribution of NOTCH signaling pathway along with TNF-α in the intestinal inflammation of ulcerative colitis. Gastroenterology and Hepatology from Bed to Bench. 2019;12:S80–s86.
   PubMedGoogle Scholar
• Zha JM, Li HS, Lin Q, et al. Interleukin 22 expands transit-amplifying cells while depleting Lgr5+ stem cells via inhibition of Wnt and Notch signaling. Cell Mol Gastroenterol Hepatol. 2019;7:255–274.
   PubMed Web of Science ®Google Scholar
• Kawamoto A, Nagata S, Anzai S, et al. Ubiquitin D is upregulated by synergy of Notch signalling and TNF-α in the inflamed intestinal epithelia of IBD patients. J Crohns Colitis. 2019;13:495–509.
   PubMed Web of Science ®Google Scholar
• Cahill EF, Tobin LM, Carty F, et al. Jagged-1 is required for the expansion of CD4+ CD25+ FoxP3+ regulatory T cells and tolerogenic dendritic cells by murine mesenchymal stromal cells. Stem Cell Res Ther. 2015;6:19.
   PubMed Web of Science ®Google Scholar
• Hue S, Kared H, Mehwish Y, et al. Notch activation on effector T cells increases their sensitivity to Treg cell-mediated suppression through upregulation of TGF-βRII expression. Eur J Immunol. 2012;42:1796–1803.
   PubMed Web of Science ®Google Scholar
• Li L, Hou X, Xu R, et al. Research review on the pharmacological effects of astragaloside IV. Fundam Clin Pharmacol. 2017;31:17–36.
   PubMed Web of Science ®Google Scholar
• Jiang XG, Sun K, Liu YY, et al. Astragaloside IV ameliorates 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis implicating regulation of energy metabolism. Sci Rep. 2017;7:41832.
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhu X, Tian X, et al. Procyanidin B2 promotes intestinal injury repair and attenuates colitis-associated tumorigenesis via suppression of oxidative stress in mouse. Antioxid Redox Signaling. 2020.
   Google Scholar
• Zhan T, Ambrosi G, Wandmacher AM, et al. MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer. Nat Commun. 2019;10:2197.
   PubMed Web of Science ®Google Scholar
• Facciorusso A, Licinio R, Carr BI, et al. MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol. 2015;9:993–1003.
   PubMed Web of Science ®Google Scholar
• Moon JH, Hong SW, Kim JE, et al. Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations. Br J Cancer. 2019;120:941–951.
   PubMed Web of Science ®Google Scholar
• Zhan T, Ambrosi G, Wandmacher AM, et al. MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer. Nat Commun. 2019;10:2197.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Adjei AA. The clinical development of MEK inhibitors. Nat Rev Clin Oncol. 2014;11:385–400.
   PubMed Web of Science ®Google Scholar
• Rinehart J, Adjei AA, Lorusso PM, et al. Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer. J Clin Oncol. 2004;22:4456–4462.
   PubMed Web of Science ®Google Scholar
• Deming DA, Cavalcante LL, Lubner SJ, et al. A phase I study of selumetinib (AZD6244/ARRY-142866), a MEK1/2 inhibitor, in combination with cetuximab in refractory solid tumors and KRAS mutant colorectal cancer. Invest New Drugs. 2016;34:168–175.
   PubMed Web of Science ®Google Scholar
• Jeong HS, Kim S, Hong SJ, et al. Black raspberry extract increased circulating endothelial progenitor cells and improved arterial stiffness in patients with metabolic syndrome: a randomized controlled trial. J Med Food. 2016;19:346–352.
   PubMed Web of Science ®Google Scholar
• Wang LS, Kuo CT, Cho SJ, et al. Black raspberry-derived anthocyanins demethylate tumor suppressor genes through the inhibition of DNMT1 and DNMT3B in colon cancer cells. Nutr Cancer. 2013;65:118–125.
   PubMed Web of Science ®Google Scholar
• Nelson KM, Dahlin JL, Bisson J, et al. The essential medicinal chemistry of curcumin. J Med Chem. 2017;60:1620–1637.
   PubMed Web of Science ®Google Scholar
• Li JJ, Yan YY, Sun HM, et al. Anti-cancer effects of pristimerin and the mechanisms: a critical review. Front Pharmacol. 2019;10:746.
   PubMed Web of Science ®Google Scholar
• Korani S, Korani M, Sathyapalan T, et al. Therapeutic effects of Crocin in autoimmune diseases: a review. Biofactors. 2019;45:835–843.
   PubMed Web of Science ®Google Scholar
• Marjaneh RM, Rahmani F, Hassanian SM, et al. Phytosomal curcumin inhibits tumor growth in colitis-associated colorectal cancer. J Cell Physiol. 2018;233:6785–6798.
   PubMed Web of Science ®Google Scholar
• Amerizadeh F, Rezaei N, Rahmani F, et al. Crocin synergistically enhances the antiproliferative activity of 5-flurouracil through Wnt/PI3K pathway in a mouse model of colitis-associated colorectal cancer. J Cell Biochem. 2018;119:10250–10261.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Bi Y, Zhong J, et al. Pristimerin suppresses colorectal cancer through inhibiting inflammatory responses and Wnt/β-catenin signaling. Toxicol Appl Pharmacol. 2020;386:114813.
   PubMed Web of Science ®Google Scholar
• Mohd Yusof YA. Gingerol and its role in chronic diseases. Adv Exp Med Biol. 2016;929:177–207.
   PubMedGoogle Scholar
• Wang S, Zhang C, Yang G, et al. Biological properties of 6-gingerol: a brief review. Nat Prod Commun. 2014;9:1027–1030.
   PubMed Web of Science ®Google Scholar
• Butt MS, Sultan MT. Ginger and its health claims: molecular aspects. Crit Rev Food Sci Nutr. 2011;51:383–393.
   PubMed Web of Science ®Google Scholar
• Ajayi BO, Adedara IA, Farombi EO. Protective mechanisms of 6-gingerol in dextran sulfate sodium-induced chronic ulcerative colitis in mice. Hum Exp Toxicol. 2018;37:1054–1068.
   PubMed Web of Science ®Google Scholar
• Nunes S, Danesi F, Del Rio D, et al. Resveratrol and inflammatory bowel disease: the evidence so far. Nutr Res Rev. 2018;31:85–97.
   PubMed Web of Science ®Google Scholar
• Lei Y, Fu P, Jun X, et al. Pharmacological properties of geraniol - a review. Planta Med. 2019;85:48–55.
   PubMed Web of Science ®Google Scholar
• Soubh AA, Abdallah DM, El-Abhar HS. Geraniol ameliorates TNBS-induced colitis: Involvement of Wnt/β-catenin, p38MAPK, NFκB, and PPARγ signaling pathways. Life Sci. 2015;136:142–150.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang Z, Fang A, et al. Resveratrol attenuates inflammatory bowel disease in mice by regulating SUMO1. Biol Pharm Bull. 2020;43:450–457.
   PubMed Web of Science ®Google Scholar
• Liu P, Yang X, Zhang H, et al. Analysis of change in microRNA expression profiles of lung cancer A549 cells treated with Radix tetrastigma hemsleyani flavonoids. Onco Targets Ther. 2018;11:4283–4300.
   PubMed Web of Science ®Google Scholar
• Wu X, Yu N, Zhang Y, et al. Radix Tetrastigma hemsleyani flavone exhibits antitumor activity in colorectal cancer via Wnt/β-catenin signaling pathway. Onco Targets Ther. 2018;11:6437–6446.
   PubMed Web of Science ®Google Scholar
• Liu CC, Cai DL, Sun F, et al. FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity. Oncogene. 2017;36:1779–1792.
   PubMed Web of Science ®Google Scholar
• Sanchez-Fidalgo S, Villegas I, Cardeno A, et al. Extra-virgin olive oil-enriched diet modulates DSS-colitis-associated colon carcinogenesis in mice. Clin Nutr. 2010;29:663–673.
   PubMed Web of Science ®Google Scholar
• Giner E, Recio MC, Ríos JL, et al. Chemopreventive effect of oleuropein in colitis-associated colorectal cancer in c57bl/6 mice. Mol Nutr Food Res. 2016;60:242–255.
   PubMed Web of Science ®Google Scholar
• Li Y, Wang S, Sun Y, et al. Apple polysaccharide protects ICR mice against colitis associated colorectal cancer through the regulation of microbial dysbiosis. Carbohydr Polym. 2020;230:115726.
   PubMed Web of Science ®Google Scholar
• Lee JH, Ki HH, Kim DK, et al. Triticum aestivum sprout extract attenuates 2,4‐dinitrochlorobenzene‐induced atopic dermatitis‐like skin lesions in mice and the expression of chemokines in human keratinocytes. Mol Med Rep. 2018;18:3461–3468.
   PubMed Web of Science ®Google Scholar
• Ki HH, Lee JH, Lee HY, et al. Triticum aestivum sprouts extract inhibits azoymethane (AOM)/dextran sodium sulfate (DSS)-induced colon carcinogenesis in mice. Nutr Cancer. 2018;70:928–937.
   PubMed Web of Science ®Google Scholar
• Luyen BT, Tai BH, Thao NP, et al. A new phenolic component from Triticum aestivum sprouts and its effects on LPS-stimulated production of nitric oxide and TNF-α in RAW 264.7 cells. Phytother Res. 2014;28:1064–1070.
   PubMed Web of Science ®Google Scholar
• Ben-Arye E, Goldin E, Wengrower D, et al. Wheat grass juice in the treatment of active distal ulcerative colitis: a randomized double-blind placebo-controlled trial. Scand J Gastroenterol. 2002;37:444–449.
   PubMed Web of Science ®Google Scholar
• Wang W, Li Y, Chen Y, et al. Ethanolic extract of traditional chinese medicine (TCM) gamboge inhibits colon cancer via the Wnt/beta-catenin signaling pathway in an orthotopic mouse model. Anticancer Res. 2018;38:1917–1925.
   PubMed Web of Science ®Google Scholar
• Sun YY, Li M, Li YY, et al. The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. Sci Rep. 2018;8:2964.
   PubMed Web of Science ®Google Scholar
• [Multicenter, randomized, controlled clinical trial on preventing antibiotic-associated diarrhea in children with pneumonia using the live Clostridium butyricum and Bifidobacterium combined Powder]. Zhonghua er ke za Zhi = Chinese Journal of Pediatrics. 2012;50:732–736.
   PubMedGoogle Scholar
• Chen D, Jin D, Huang S, et al. Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota. Cancer Lett. 2020;469:456–467.
   PubMed Web of Science ®Google Scholar
• Munding J, Ziebarth W, Pox CP, et al. The influence of 5-aminosalicylic acid on the progression of colorectal adenomas via the β-catenin signaling pathway. Carcinogenesis. 2012;33:637–643.
   PubMed Web of Science ®Google Scholar
• Stolfi C, Pallone F, Monteleone G. Colorectal cancer chemoprevention by mesalazine and its derivatives. J Biomed Biotechnol. 2012;2012:980458.
   PubMedGoogle Scholar
• Lopez A, Peyrin-Biroulet L. 5-Aminosalicylic acid and chemoprevention: does it work? Dig Dis. 2013;31:248–253.
   PubMed Web of Science ®Google Scholar
• Bos CL, Diks SH, Hardwick JC, et al. Protein phosphatase 2A is required for mesalazine-dependent inhibition of Wnt/beta-catenin pathway activity. Carcinogenesis. 2006;27:2371–2382.
   PubMed Web of Science ®Google Scholar
• Parenti S, Montorsi L, Fantini S, et al. KLF4 mediates the effect of 5-ASA on the β-catenin pathway in colon cancer cells. Cancer Prev Res (Phila). 2018;11:503–510.
   PubMed Web of Science ®Google Scholar
• Rubin DT, LoSavio A, Yadron N, et al. Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis. Clin Gastroenterol Hepatol. 2006;4:1346–1350.
   PubMed Web of Science ®Google Scholar
• Teneggi V, Ng M, Tan DS, et al. 152O A phase 1, first-in-human dose escalation study of ETC-159 in advanced or metastatic solid tumours. Ann Oncol. 2016;27(suppl_9). doi:10.1093/annonc/mdw579
   Google Scholar
• Thorvaldsen TE, Pedersen NM, Wenzel EM, et al. Structure, dynamics, and functionality of tankyrase inhibitor-induced degradasomes. Mol Cancer Res. 2015;13:1487–1501.
   PubMed Web of Science ®Google Scholar
• Lau T, Chan E, Callow M, et al. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth. Cancer Res. 2013;73:3132–3144.
   PubMed Web of Science ®Google Scholar
• Verardo V, Gomez-Caravaca AM, Arraez-Roman D, et al. Recent advances in phospholipids from colostrum, milk and dairy by-products. Int J Mol Sci. 2017;18:173.
   Web of Science ®Google Scholar
• Vors C, Joumard-Cubizolles L, Lecomte M, et al. Milk polar lipids reduce lipid cardiovascular risk factors in overweight postmenopausal women: towards a gut sphingomyelin-cholesterol interplay. Gut. 2020;69:487–501.
   PubMed Web of Science ®Google Scholar
• Wang X, Kong X, Qin Y, et al. Milk phospholipids ameliorate mouse colitis associated with colonic goblet cell depletion via the Notch pathway. Food Funct. 2019;10:4608–4619.
   PubMed Web of Science ®Google Scholar
• Parodi PW. Cows’ milk fat components as potential anticarcinogenic agents. J Nutr. 1997;127:1055–1060.
   PubMed Web of Science ®Google Scholar
• Gupta V, Garg R. Probiotics. Indian J Med Microbiol. 2009;27:202–209.
   PubMed Web of Science ®Google Scholar
• Wu H, Ye L, Lu X, et al. Lactobacillus acidophilus alleviated salmonella-induced goblet cells loss and colitis by notch pathway. Mol Nutr Food Res. 2018;62:e1800552.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang T, Guo C, et al. Bacillus subtilis RZ001 improves intestinal integrity and alleviates colitis by inhibiting the Notch signalling pathway and activating ATOH-1. Pathog Dis. 2020;78:ftaa016.
   PubMed Web of Science ®Google Scholar
• Xie S, Zhao S, Jiang L, et al. Lactobacillus reuteri stimulates intestinal epithelial proliferation and induces differentiation into goblet cells in young chickens. J Agric Food Chem. 2019;67:13758–13766.
   PubMed Web of Science ®Google Scholar
• Jieqiong W. Integrated traditional chinese and western medicine in the treatment of 225 cases of ulcerative colitis via colon. Modern Tradit Chin Med. 2010;30:6–7.
   Google Scholar
• Lin JC, Wu JQ, Wang F, et al. QingBai decoction regulates intestinal permeability of dextran sulphate sodium-induced colitis through the modulation of notch and NF-κB signalling. Cell Prolif. 2019;52:e12547.
   PubMed Web of Science ®Google Scholar
• Shinoda M, Shin-Ya M, Naito Y, et al. Early-stage blocking of Notch signaling inhibits the depletion of goblet cells in dextran sodium sulfate-induced colitis in mice. J Gastroenterol. 2010;45:608–617.
   PubMed Web of Science ®Google Scholar
• Ahmed I, Roy BC, Raach RT, et al. Enteric infection coupled with chronic Notch pathway inhibition alters colonic mucus composition leading to dysbiosis, barrier disruption and colitis. PLoS One. 2018;13:e0206701.
   PubMed Web of Science ®Google Scholar
• Yin J, Yang K, Zhou C, et al. Aryl hydrocarbon receptor activation alleviates dextran sodium sulfate-induced colitis through enhancing the differentiation of goblet cells. Biochem Biophys Res Commun. 2019;514:180–186.
   PubMed Web of Science ®Google Scholar
• Kummar S, O'Sullivan Coyne G, Do KT, et al. Clinical activity of the γ-secretase inhibitor PF-03084014 in adults with desmoid tumors (aggressive fibromatosis). J Clin Oncol. 2017;35:1561–1569.
   PubMed Web of Science ®Google Scholar
• Cook N, Basu B, Smith DM, et al. A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma. Br J Cancer. 2018;118:793–801.
   PubMed Web of Science ®Google Scholar
• Arcaroli JJ, Powell RW, Varella-Garcia M, et al. ALDH + tumor-initiating cells exhibiting gain in NOTCH1 gene copy number have enhanced regrowth sensitivity to a γ-secretase inhibitor and irinotecan in colorectal cancer. Mol Oncol. 2012;6:370–381.
   PubMed Web of Science ®Google Scholar
• KleinJan A, Tindemans I, Montgomery JE, et al. The Notch pathway inhibitor stapled α-helical peptide derived from mastermind-like 1 (SAHM1) abrogates the hallmarks of allergic asthma. J Allergy Clin Immunol. 2018;142:76–85 e8.
   PubMed Web of Science ®Google Scholar
• Kiyomatsu-Oda M, Uchi H, Morino-Koga S, et al. Protective role of 6-formylindolo[3,2-b]carbazole (FICZ), an endogenous ligand for arylhydrocarbon receptor, in chronic mite-induced dermatitis. J Dermatol Sci. 2018;90:284–294.
   PubMed Web of Science ®Google Scholar
• Dandawate P, Subramaniam D, Panovich P, et al. Cucurbitacin B and I inhibits colon cancer growth by targeting the Notch signaling pathway. Sci Rep. 2020;10:1290.
   PubMed Web of Science ®Google Scholar
• Piazzi G, D'Argenio G, Prossomariti A, et al. Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota. Int J Cancer. 2014;135:2004–2013.
   PubMed Web of Science ®Google Scholar
• Ishiguro H, Okubo T, Kuwabara Y, et al. NOTCH1 activates the Wnt/β-catenin signaling pathway in colon cancer. Oncotarget. 2017;8:60378–60389.
   PubMedGoogle Scholar
• Garg P, Jeppsson S, Dalmasso G, et al. Notch1 regulates the effects of matrix metalloproteinase-9 on colitis-associated cancer in mice. Gastroenterology. 2011;141:1381–1392.
   PubMed Web of Science ®Google Scholar
• Patel RV, Mistry BM, Shinde SK, et al. Therapeutic potential of quercetin as a cardiovascular agent. Eur J Med Chem. 2018;155:889–904.
   PubMed Web of Science ®Google Scholar
• Eid HM, Haddad PS. The antidiabetic potential of quercetin: underlying mechanisms. Curr Med Chem. 2017;24:355–364.
   PubMed Web of Science ®Google Scholar
• Li Y, Wang Z, Jin J, et al. Quercetin pretreatment enhances the radiosensitivity of colon cancer cells by targeting Notch-1 pathway. Biochem Biophys Res Commun. 2020;523:947–953.
   PubMed Web of Science ®Google Scholar
• Sarrica A, Kirika N, Romeo M, et al. Safety and toxicology of magnolol and honokiol. Planta Med. 2018;84:1151–1164.
   PubMed Web of Science ®Google Scholar
• Ponnurangam S, Mammen JM, Ramalingam S, et al. Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells. Mol Cancer Ther. 2012;11:963–972.
   PubMed Web of Science ®Google Scholar
• Avila-Carrasco L, Majano P, Sánchez-Toméro JA, et al. Natural plants compounds as modulators of epithelial-to-mesenchymal transition. Front Pharmacol. 2019;10:715.
   PubMed Web of Science ®Google Scholar
• Zhou YX, Xin HL, Rahman K, et al. Portulaca oleracea L.: a review of phytochemistry and pharmacological effects. Biomed Res Int. 2015;2015:925631.
   PubMed Web of Science ®Google Scholar
• Kim Y, Lim HJ, Jang HJ, et al. Portulaca oleracea extracts and their active compounds ameliorate inflammatory bowel diseases in vitro and in vivo by modulating TNF-α, IL-6 and IL-1β signalling. Food Res Int. 2018;106:335–343.
   PubMed Web of Science ®Google Scholar
• Jin H, Chen L, Wang S, et al. Portulaca oleracea extract can inhibit nodule formation of colon cancer stem cells by regulating gene expression of the Notch signal transduction pathway. Tumour Biol. 2017;39:101042831770869.
   Google Scholar
• Lu HY, Zu YX, Jiang XW, et al. Novel ADAM-17 inhibitor ZLDI-8 inhibits the proliferation and metastasis of chemo-resistant non-small-cell lung cancer by reversing Notch and epithelial mesenchymal transition in vitro and in vivo. Pharmacol Res. 2019;148:104406.
   PubMed Web of Science ®Google Scholar
• Lu HY, Chu HX, Tan YX, et al. Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo. Life Sci. 2020;244:117343.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li D, Jiang Q, et al. Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells. Cell Death Dis. 2018;9:743.
   PubMed Web of Science ®Google Scholar
• Li DD, Zhao CH, Ding HW, et al. A novel inhibitor of ADAM17 sensitizes colorectal cancer cells to 5-fluorouracil by reversing Notch and epithelial-mesenchymal transition in vitro and in vivo. Cell Prolif. 2018;51:e12480.
   PubMed Web of Science ®Google Scholar
• Dosch J, Ziemke E, Wan S, et al. Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency. Oncotarget. 2017;8:65090–65099.
   PubMedGoogle Scholar
• Suliman MA, Zhang Z, Na H, et al. Niclosamide inhibits colon cancer progression through downregulation of the Notch pathway and upregulation of the tumor suppressor miR-200 family. Int J Mol Med. 2016;38:776–784.
   PubMed Web of Science ®Google Scholar
• Sack U, Walther W, Scudiero D, et al. Novel effect of antihelminthic niclosamide on S100A4-mediated metastatic progression in colon cancer. J Natl Cancer Inst. 2011;103:1018–1036.
   PubMedGoogle Scholar
• Astudillo L, Da Silva TG, Wang Z, et al. The small molecule IMR-1 inhibits the Notch transcriptional activation complex to suppress tumorigenesis. Cancer Res. 2016;76:3593–3603.
   PubMed Web of Science ®Google Scholar
• Rejhová A, Opattová A, Čumová A, et al. Natural compounds and combination therapy in colorectal cancer treatment. Eur J Med Chem. 2018;144:582–594.
   PubMed Web of Science ®Google Scholar
• Aleksic T, Feller SM. Gamma-secretase inhibition combined with platinum compounds enhances cell death in a large subset of colorectal cancer cells. Cell Commun Signal. 2008;6:8.
   PubMedGoogle Scholar
• Kyula JN, Van Schaeybroeck S, Doherty J, et al. Chemotherapy-induced activation of ADAM-17: a novel mechanism of drug resistance in colorectal cancer. Clin Cancer Res. 2010;16:3378–3389.
   PubMed Web of Science ®Google Scholar
• Madonna R, Pieragostino D, Cufaro MC, et al. Ponatinib induces vascular toxicity through the Notch-1 signaling pathway. J Clin Med. 2020;9:820.
   Web of Science ®Google Scholar
• Funck-Brentano T, Nilsson KH, Brommage R, et al. Porcupine inhibitors impair trabecular and cortical bone mass and strength in mice. Journal of Endocrinology. 2018;238:13–23.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Katavolos P, Nguyen T, et al. Tankyrase inhibition causes reversible intestinal toxicity in mice with a therapeutic index <1. Toxicol Pathol. 2016;44:267–278.
   PubMed Web of Science ®Google Scholar